As one of the leading cancer research enterprises in the U.S., we’re at the forefront of research that is leading to new therapies for our patients.
We perform the most cancer surgeries in New England.
We are home to more than 1,000 active clinical trials per year, ensuring that our patients have access to pioneering therapies that move breakthrough science directly into care.